Michael Catelani - Oct 31, 2023 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
President, COO & CFO
Signature
/s/ Michael J. Catelani
Stock symbol
ANIX
Transactions as of
Oct 31, 2023
Transactions value $
$3,005
Form type
4
Date filed
11/2/2023, 10:58 AM
Previous filing
Jul 21, 2023
Next filing
Jan 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIX Common Stock Award $3K +1.12K +4.19% $2.69 27.8K Oct 31, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person purchased the shares of common stock reported hereunder pursuant to the Anixa Biosciences, Inc. Employee Stock Purchase Plan (the "Plan") which satisfies the requirements of Section 423 of the Internal Revenue Code. The reporting person's purchase of the shares of common stock is exempt from Section 16(b) under Rule 16b-3(c) and is exempt from the reporting requirements of Section 16 by virtue of Rule 16a-3(f)(1)(i)(B), however the reporting person has elected to voluntarily report the acquisition of the shares.
F2 In accordance with the Plan, the shares were purchased based on 85% of the closing price of Anixa Biosciences, Inc. common stock on October 31, 2023.